BRCA1 associates with human papillomavirus type 18 E2 and stimulates E2-dependent transcription

Biochemical and Biophysical Research Communications

Volumn 305, Issue 4, 2003, Pages 1008-1016

  Kim, Jiyun ^a   Lee, Daeyoup ^a   Hwang, Sun Gwan ^a   Hwang, Eun Seong ^b   Choe, Joonho ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b University of Seoul   (South Korea)

Author keywords

BRCA1; Coactivator; Papillomavirus

Indexed keywords

BRCA1 PROTEIN; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHROMATIN STRUCTURE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; VIRUS STRAIN; VIRUS TYPING; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0038242281     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00880-5     Document Type: Article

References (39)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W.et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
2. Thomas J.E., Smith M., Rubinfeld B., Gutowski M., Beckmann R.P., Polakis P. Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J. Biol. Chem. 271:1996;28630-28635.
3. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., Livingston D.M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90:1997;425-435.
4. Saurin A.J., Borden K.L., Boddy M.N., Freemont P.S. Does this have a familiar RING? Trends Biochem. Sci. 21:1996;208-214.
5. Monteiro A.N., August A., Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA. 93:1996;13595-13599.
6. Chapman M.S., Verma I.M. Transcriptional activation by BRCA1. Nature. 382:1996;678-679.
7. Hayes F., Cayanan C., Barilla D., Monteiro A.N. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation. Cancer Res. 60:2000;2411-2418.
8. Nadeau G., Boufaied N., Moisan A., Lemieux K.M., Cayanan C., Monteiro A.N., Gaudreau L. BRCA1 can stimulate gene transcription by a unique mechanism. EMBO Rep. 1:2000;260-265.
9. Scully R., Anderson S.F., Chao D.M., Wei W., Ye L., Young R.A., Livingston D.M., Parvin J.D. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA. 94:1997;5605-5610.
10. Pao G.M., Janknecht R., Ruffner H., Hunter T., Verma I.M. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc. Natl. Acad. Sci. USA. 97:2000;1020-1025.
11. Ouchi T., Lee S.W., Ouchi M., Aaronson S.A., Horvath C.M. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-γ target genes. Proc. Natl. Acad. Sci. USA. 97:2000;5208-5213.
12. Wang Q., Zhang H., Kajino K., Greene M.I. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene. 17:1998;1939-1948.
13. Yu X., Wu L.C., Bowcock A.M., Aronheim A., Baer R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273:1998;25388-25392.
14. Ouchi T., Monteiro A.N., August A., Aaronson S.A., Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA. 95:1998;2302-2306.
15. Houvras Y., Benezra M., Zhang H., Manfredi J.J., Weber B.L., Licht J.D. BRCA1 physically and functionally interacts with ATF1. J. Biol. Chem. 275:2000;36230-36237.
16. M. Benezra, N. Chevallier, D.J. Morrison, T.K. MacLachlan, W.S. El-Deiry, J.D. Licht, BRCA1 augments transcription by the NF-κ B transcription factor by binding to the Rel domain of the p65/RelA subunit, J. Biol. Chem. (2003) in press.
17. Kawai H., Li H., Chun P., Avraham S., Avraham H.K. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene. 21:2002;7730-7739.
18. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta. 1288:1996;F55-F78.
19. McBride A.A., Schlegel R., Howley P.M. The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. EMBO J. 7:1988;533-539.
20. McBride A.A., Byrne J.C., Howley P.M. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc. Natl. Acad. Sci. USA. 86:1989;510-514.
21. Choe J., Vaillancourt P., Stenlund A., Botchan M. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J. Virol. 63:1989;1743-1755.
22. McBride A.A., Romanczuk H., Howley P.M. The papillomavirus E2 regulatory proteins. J. Biol. Chem. 266:1991;18411-18414.
23. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314:1985;111-114.
24. Yao J.M., Breiding D.E., Androphy E.J. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J. Virol. 72:1998;1013-1019.
25. Steger D.J., Workman J.L. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J. 16:1997;2463-2472.
26. Demeret C., Yaniv M., Thierry F. The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. J. Virol. 68:1994;7075-7082.
27. Breiding D.E., Sverdrup F., Grossel M.J., Moscufo N., Boonchai W., Androphy E.J. Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol. Cell. Biol. 17:1997;7208-7219.
28. Peng Y.C., Breiding D.E., Sverdrup F., Richard J., Androphy E.J. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 74:2000;5872-5879.
29. Lee D., Lee B., Kim J., Kim D.W., Choe J. cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription. J. Biol. Chem. 275:2000;7045-7051.
30. Scully R., Ganesan S., Brown M., De Caprio J.A., Cannistra S.A., Feunteun J., Schnitt S., Livingston D.M. Location of BRCA1 in human breast and ovarian cancer cells. Science. 272:1996;123-126.
31. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
32. Somasundaram K., Zhang H., Zeng Y.X., Houvras Y., Peng Y., Wu G.S., Licht J.D., Weber B.L., El-Deiry W.S. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 389:1997;187-190.
33. Zhang H., Somasundaram K., Peng Y., Tian H., Bi D., Weber B.L., El-Deiry W.S. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 16:1998;1713-1721.
34. Cui J.Q., Wang H., Reddy E.S., Rao V.N. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b. Oncol. Rep. 5:1998;585-589.
35. Chai Y.L., Cui J., Shao N., Shyam E., Reddy P., Rao V.N. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene. 18:1999;263-268.
36. Couch F.J., Weber B.L. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum. Mutat. 8:1996;8-18.
37. Nishimura A., Ono T., Ishimoto A., Dowhanick J.J., Frizzell M.A., Howley P.M., Sakai H. Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J. Virol. 74:2000;3752-3760.
38. Goodwin E.C., Naeger L.K., Breiding D.E., Androphy E.J., DiMaio D. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J. Virol. 72:1998;3925-3934.
39. Desaintes C., Goyat S., Garbay S., Yaniv M., Thierry F. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene. 18:1999;4538-4545.